Email ID
Password
Pfizer is facing more disappointment with the development of some of its most advanced anticancers after Sutent (sunitinib) failed two more Phase III trials in ...
In the run up to the general election the UK's three main political parties say they will support the life sciences industry. But victory for any party could ...
Roche 's Avastin (bevacizumab), the world's best-selling cancer drug, has failed to prolong overall survival in its only Phase III trial in advanced prostate ...
The European Commission will provide €12 million in funding for two new research projects which will develop novel influenza treatments, including against both ...
 
BioInvent and Human Genome Sciences (HGS) have signed a deal to discover, develop and commercialise therapeutic monolconal antibodies that target antigens discovered by HGS. The deal will initially ...
BT Pharma has raised €13.1 million in a private financing round and has changed its name to Genticel. Genticel will use the funding to focus its operations on the prevention of cervical cancer in ...
AVEO Pharmaceuticals has finally launched its IPO, after delaying the pricing by a day. The cancer-focused biopharmaceutical company priced 9 million shares of its common stock at $9 per share after ...
Bilcare Global Clinical Supplies, a provider of clinical trial supplies and services from India, plans to open a second unit in Crickhowell, Wales, in the UK. The new 30,000ft 2 unit is expected to ...
 
The US FDA was established in 1931, but only three years ago did it get the power to order drug makers to conduct safety studies of products that have already been approved and put into general use. ...
The US FDA has issued Actelion with a complete response letter for its drug Zavesca (miglustat), for the treatment of progressive neurological manifestations in adults and children with Niemann-Pick ...
Takara Bio has signed a collaborative research agreement with the University of Pennsylvania in the US for the co-development of an innovative gene-based therapy for HIV. The Japanese firm will work ...
PTC Therapeutics and Genzyme 's ataluren, an experimental nonsense mutation suppressor, has failed in nonsense mutation Duchenne/Becker Muscular Dystrophy (nmDBMD), show top-line Phase IIb results. ...
 
Germany's health ministry is planning to introduce compulsory price negotiations for patented drugs between the pharmaceutical industry and health insurers, it confirmed to Scrip. The measure could ...
GlaxoSmithkline has filed a motion in a US federal court for a preliminary injunction to bar Teva Pharmaceutical Industries from an apparent planned May launch of a generic version of GSK's HIV/AIDS ...
Raimondas Sukys has become Lithuania's new health minister taking over the post from the acting health minister Ingrida Simonyte . Lithuania's president Dalia Grybauskaite has asked him to go ahead ...
The international humanitarian body Médecins Sans Frontières (MSF) has written to the Indian prime minister, Dr Manmohan Singh , expressing concern that the EU-India free trade agreement, which will ...
 
Clinton-Bush Haiti fund appoints board The Clinton Bush Haiti Fund (CBHF), set up by former US presidents Bill Clinton and George W ...
Iain McGill joins EUSA Pharma EUSA Pharma (UK/US), a speciality pharmaceutical company focused on oncology, pain control and ...
New appointment at Affimed Therapeutics Affimed Therapeutics (Germany) has appointed Dr Christian Hucke to take over responsibility for ...

Keeping the faith with anticancers
12 March 2010
Peter Charlish
It has been a bad week for anticancer drug development, with two late-stage projects coming to ...

Market Insight: Big pharma hit by Greece's fiscal crisis
09 March 2010

Hospitals' failure to pay pharmaceutical companies and newly announced price cuts are just some of ...

 Market Insight - Fear gives way to prudence a...

How to run clinical trials in the Middle East - why the GCC?
04 March 2010

A grouping of Middle Eastern countries came together under the auspices of the Gulf Co-operation ...

How to run clinical trials in the Middle East - Jordan
04 March 2010

Jordan has a population of 6.35 million and its GDP per capita is $5,000, while its healthcare ...

Genzyme's gambit: A hedge against Carl Icahn
18 February 2010
Christopher Spillane
The fall in Genzyme 's share price made it an obvious target. The Massachusetts based biotech ...

Logos are said to be an important part of an organisation's branding. Really good logos contribute ...

Jeff George took over as head of Sandoz, Novartis's generics business, in late 2008. With a big ...

CPhI Worldwide 2009
13 October 2009
Scrip's official preview of CPhI Worldwide, ICSE, P-MEC and BioPh 2009

Scrip's Stock Tracker February 2010
12 March 2010
Ashley Yeo
Talk of dividends being under threat at companies such as Bristol-Myers Squibb , Pfizer and Lilly , ...

JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36